表紙
市場調查報告書

COVID-19診斷檢驗的全球市場 - 市場考察,競爭,預測:2020年∼2025年

Global COVID-19 Diagnostic Testing Market - Analysis By Test Type (Molecular, Serology), End-User, By Region, By Country (2020 Edition): Market Insights, Competition and Forecast (2020-2025)

出版商 Azoth Analytics 商品編碼 939737
出版日期 內容資訊 英文 280 Pages
訂單完成後即時交付
價格
COVID-19診斷檢驗的全球市場 - 市場考察,競爭,預測:2020年∼2025年 Global COVID-19 Diagnostic Testing Market - Analysis By Test Type (Molecular, Serology), End-User, By Region, By Country (2020 Edition): Market Insights, Competition and Forecast (2020-2025)
出版日期: 2020年05月31日內容資訊: 英文 280 Pages
簡介

全球COVID-19診斷檢驗市場由於在全世界病例數急速增加,2020年達到444億8180萬美元。

本報告提供全球COVID-19診斷檢驗市場相關調查分析,提供市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 調查範圍和調查手法

第2章 策略性建議

第3章 全球COVID-19診斷檢驗市場:產品預測

第4章 全球COVID-19診斷檢驗市場:規模與預測

  • 市場規模:各金額
  • 市場規模:COVID-19檢查別

第5章 全球COVID-19診斷檢驗市場:各檢驗類型

  • 競爭模式
  • 分子檢驗
  • 血清檢驗

第6章 全球COVID-19診斷檢驗市場:各終端用戶

  • 競爭模式
  • 公共衛生研究所
  • 民間/商業研究所
  • 其他

第7章 全球COVID-19診斷檢驗市場:各地區分析

  • 競爭模式

第8章 南北美洲的COVID-19診斷檢驗市場:各檢驗類型,各終端用戶

  • 規模與預測:各金額
  • 規模與預測:COVID-19檢查別
  • 主要企業
  • 各檢驗類型
  • 各終端用戶
  • 各國分析
  • 競爭模式
  • 美國
  • 加拿大
  • 巴西

第9章 歐洲的COVID-19診斷檢驗市場:各檢驗類型,各終端用戶

第10章 亞太地區的COVID-19診斷檢驗市場:各檢驗類型,各終端用戶

第11章 全球COVID-19診斷檢驗市場動態

第12章 COVID-19疫苗開發

第13章 競爭情形

第14章 企業簡介 (營業內容,財務分析,事業策略)

  • Biomerieux
  • Roche Holding AG
  • Siemens Healthineers
  • Abbott Laboratories
  • Becton Dickinson
  • Thermo Fisher Scientific
  • Cepheid
  • BGI Genomics
  • Seegene
  • PerkinElmer
目錄

Executive Summary

The Global COVID-19 Diagnostic Testing Market is estimated to be valued at USD 44481.8 million for the year 2020 owing to rapid increase in number of coronavirus cases across the globe which boosts the demand for COVID-19 diagnostic tests. The COVID-19 diagnostic tests are critical in the management of the current pandemic for accurate diagnosis as well as to tackle the spread of the infection. Also, Global COVID-19 Diagnostic Testing market in terms of COVID-19 Tests is expected to reach the number of 329.17 million in year 2020.

In March 2020, the Food and Drug Administration (FDA) gave Emergency Use Authorization (EUA) to the first POC test-Xpert Xpress test made by Cepheid-for COVID-19 analysis. Abbott and Chembio Diagnostics are among the dynamic market players working for the purpose of care commercial center. The WHO has encouraged healthcare organizations to focus on COVID-19 indicative testing in light of this emergency.

The companies are also adopting profitable strategic moves to gain a competitive edge in the market. For example, in May 2020, Quest Diagnostics announced its collaboration with Ortho Clinical Diagnostics aimed at expansion of COVID-19 antibody testing across more than 20 laboratories of Quest throughout U.S. The company applied VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test of Ortho to ramp up the coronavirus testing in patients.

Among the Test Type segment in the COVID-19 Diagnostic Testing market (Molecular Tests, Serology Tests), Molecular Test type segment has been gaining popularity among other segments. Robust funding and speculations by public as well as private organizations are relied upon to impel molecular diagnostic organizations to create COVID-19 symptomatic products, in this way driving the market. Based on End-User segment, Private or Commercial labs segment holds the major share in the COVID-19 diagnostic testing market followed by Public health labs and hospitals. Due to the growing number of COVID-19 cases across the globe, it has become imperative for the government of the various countries to involve a greater number of private or commercial firms in providing diagnostic testing in order to enhance the testing capacity to detect the virus.

Scope of the Report

  • The report analyses the COVID-19 Diagnostic Testing market by Value and by COVID-19 Tests.
  • The report analyses the COVID-19 Diagnostic Testing Market by Test Type (Molecular Tests, Serology Tests).
  • The report assesses the COVID-19 Diagnostic Testing market by End-User (Public Health Labs, Private or Commercial Labs, Others).
  • The Global COVID-19 Diagnostic Testing Market has been analysed by Region (Americas, Europe, Asia Pacific) and by Country (United States, Canada, Brazil, Germany, France, Italy, United Kingdom, Spain, Russia, China, Japan, India, South Korea, Singapore)
  • The major trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, COVID-19 vaccine development. The companies analysed in the report include Biomerieux, Roche Holding AG, Siemens Healthineers, Abbott Laboratories, Becton Dickinson, Thermo Fisher Scientific, Cepheid, BGI Genomics, Seegene, PerkinElmer.
  • The report presents the analysis of COVID-19 Diagnostic Testing market for the forecast period of 2020-2025.

Key Target Audience

  • COVID-19 Diagnostic Test Kit manufacturers, dealers, and suppliers
  • Pharmaceutical companies
  • Global Healthcare Agencies
  • Consulting and Advisory Firms
  • Government and Policy Makers
  • Investment Banks and Equity Firms
  • Regulatory Authorities

Table of Contents

1. Report Scope and Methodology

  • 1.1 Scope of the Report
  • 1.2 Research Methodology
  • 1.3 Executive Summary

2. Strategic Recommendations

3. Global COVID-19 Diagnostic Testing Market: Product Outlook

4. Global COVID-19 Diagnostic Testing Market: Sizing and Forecast

  • 4.1 Market Size, By Value, Year 2020-2025
  • 4.2 Market Size, By COVID-19 Tests, Year 2020-2025

5. Global COVID-19 Diagnostic Testing Market Segmentation By Test Type

  • 5.1 Competitive Scenario of Global COVID-19 Diagnostic Testing: By Test Type
  • 5.2 Molecular Tests - Market Size and Forecast (2020-2025)
  • 5.3 Serology Tests - Market Size and Forecast (2020-2025)

6. Global COVID-19 Diagnostic Testing Market Segmentation By End-User

  • 6.1 Competitive Scenario of Global COVID-19 Diagnostic Testing: By End-User
  • 6.2 Public Health Labs - Market Size and Forecast (2020-2025)
  • 6.3 Private or Commercial Labs - Market Size and Forecast (2020-2025)
  • 6.4 Others - Market Size and Forecast (2020-2025)

7. Global COVID-19 Diagnostic Testing Market: Regional Analysis

  • 7.1 Competitive Scenario of Global COVID-19 Diagnostic Testing: By Region, By Value

8. Americas COVID-19 Diagnostic Testing Market: Segmentation By Test Type, End-User (2020-2025)

  • 8.1 Americas COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 8.2 Americas COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 8.3 Americas COVID-19 Diagnostic Testing Market - Prominent Companies
  • 8.4 Market Segmentation By Test Type (Molecular Tests, Serology Tests)
  • 8.5 Market Segmentation By End-User (Public Health Labs, Private or Commercial Labs, Others)
  • 8.6 Americas COVID-19 Diagnostic Testing Market: Country Analysis
  • 8.7 Competitive Scenario of Americas COVID-19 Diagnostic Testing: By Country, By Value
  • 8.8 United States COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 8.9 United States COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 8.10 United States COVID-19 Diagnostic Testing Market: Prominent Players
  • 8.11 United States COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User
  • 8.12 Canada COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 8.13 Canada COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 8.14 Canada COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User
  • 8.15 Brazil COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 8.16 Brazil COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 8.17 Brazil COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User

9. Europe COVID-19 Diagnostic Testing Market: Segmentation By Test Type, End-User (2020-2025)

  • 9.1 Europe COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 9.2 Europe COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 9.3 Europe COVID-19 Diagnostic Testing Market - Prominent Companies
  • 9.4 Market Segmentation By Test Type (Molecular Tests, Serology Tests)
  • 9.5 Market Segmentation By End-User (Public Health Labs, Private or Commercial Labs, Others)
  • 9.6 Europe COVID-19 Diagnostic Testing Market: Country Analysis
  • 9.7 Competitive Scenario of Europe COVID-19 Diagnostic Testing: By Country, By Value
  • 9.8 Germany COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 9.9 Germany COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 9.10 Germany COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User
  • 9.11 France COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 9.12 France COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 9.13 France COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User
  • 9.14 United Kingdom COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 9.15 United Kingdom COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 9.16 United Kingdom COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User
  • 9.17 Spain COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 9.18 Spain COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 9.19 Spain COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User
  • 9.20 Italy COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 9.21 Italy COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 9.22 Italy COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User
  • 9.23 Russia COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 9.24 Russia COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 9.25 Russia COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User

10. Asia Pacific COVID-19 Diagnostic Testing Market: Segmentation By Test Type, End-User (2020-2025)

  • 10.1 Asia Pacific COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 10.2 Asia Pacific COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 10.3 Asia Pacific COVID-19 Diagnostic Testing Market - Prominent Companies
  • 10.4 Market Segmentation By Test Type (Molecular Tests, Serology Tests)
  • 10.5 Market Segmentation By End-User (Public Health Labs, Private or Commercial Labs, Others)
  • 10.6 Asia Pacific COVID-19 Diagnostic Testing Market: Country Analysis
  • 10.7 Competitive Scenario of Asia Pacific COVID-19 Diagnostic Testing: By Country, By Value
  • 10.8 China COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 10.9 China COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 10.10 China COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User
  • 10.11 Japan COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 10.12 Japan COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 10.13 Japan COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User
  • 10.14 India COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 10.15 India COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 10.16 India COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User
  • 10.17 South Korea COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 10.18 South Korea COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 10.19 South Korea COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User
  • 10.20 Singapore COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
  • 10.21 Singapore COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
  • 10.22 Singapore COVID-19 Diagnostic Testing Market Segmentation By Test Type, End-User

11. Global COVID-19 Diagnostic Testing Market Dynamics

  • 11.1 Global COVID-19 Diagnostic Testing Market Drivers
  • 11.2 Global COVID-19 Diagnostic Testing Market Restraints
  • 11.3 Global COVID-19 Diagnostic Testing Market Trends

12. COVID-19 Vaccine Development

  • 12.1 Overview of Vaccine Development
  • 12.2 Overview of the leading vaccine candidates

13. Competitive Landscape

14. Company Profiles (Business Description, Financial Analysis, Business Strategy)

  • 14.1 Biomerieux
  • 14.2 Roche Holding AG
  • 14.3 Siemens Healthineers
  • 14.4 Abbott Laboratories
  • 14.5 Becton Dickinson
  • 14.6 Thermo Fisher Scientific
  • 14.7 Cepheid
  • 14.8 BGI Genomics
  • 14.9 Seegene
  • 14.10 PerkinElmer

List of Figures

  • Figure 1: Global COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 2: Global COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 3: Global Distribution of COVID-19 Cases, By Country (%), Updated upto 12th May, 2020
  • Figure 4: Total COVID-19 Tests per thousand people, May 12, 2020
  • Figure 5: Share of COVID-19 Tests that were positive, May 12, 2020
  • Figure 6: Total Confirmed COVID-19 deaths per million people, May 12, 2020
  • Figure 7: Percentage of Population Aged 65 or over, 2020
  • Figure 8: Global COVID-19 Data, Last Updated to 20th May, 2020
  • Figure 9: Global Population Projection (In Billion), 2020-2040
  • Figure 10: Countries with highest share of pop aged 65+, 2020
  • Figure 11: Countries with the most critical care beds per capita
  • Figure 12: COVID-19 Testing Policies, May 20,2020
  • Figure 13: Global COVID-19 Diagnostic Testing Market Share- By Test Type, Year 2020 & 2025
  • Figure 14: Global COVID-19 Diagnostic Testing Market- By Molecular Test, By Value (USD Million), 2020-2025
  • Figure 15: Global COVID-19 Diagnostic Testing Market- By Serology Test, By Value (USD Million), 2020-2025
  • Figure 16: Global COVID-19 Diagnostic Testing Market Share- By End-User, Year 2020 & 2025
  • Figure 17: Global COVID-19 Diagnostic Testing Market- By Public Health Labs, By Value (USD Million), 2020-2025
  • Figure 18: Global COVID-19 Diagnostic Testing Market- By Private or Commercial Labs, By Value (USD Million), 2020-2025
  • Figure 19: Global COVID-19 Diagnostic Testing Market- By Others, By Value (USD Million), 2020-2025
  • Figure 20: Global COVID-19 Diagnostic Testing Market Share- By Region, By Value, Year 2020 & 2025
  • Figure 21: Americas COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 22: Americas COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 23: North America Total COVID-19 Tests per thousand people, May 18, 2020
  • Figure 24: South America Total COVID-19 Tests per thousand people, May 18, 2020
  • Figure 25: North America COVID-19 Testing Policies, May 20,2020
  • Figure 26: South America COVID-19 Testing Policies, May 20,2020
  • Figure 27: Americas COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 28: Americas Population Projection (In Million), 2020-2035
  • Figure 29: Americas COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 30: Americas COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 31: Americas COVID-19 Diagnostic Testing Market Share- By Country, By Value, Year 2020 & 2025
  • Figure 32: United States COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 33: United States COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 34: United States COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 35: United States COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 36: Millions of People Aged 65 years or above
  • Figure 37: United States Population Projection (In Million), 2020-2035
  • Figure 38: United States COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 39: Canada COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 40: Canada COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 41: Canada COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 42: Canada COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 43: Canada Population Projection (In Million), 2020-2035
  • Figure 44: Canada COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 45: Brazil COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 46: Brazil COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 47: Brazil COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 48: Brazil COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 49: Brazil Population Projection (In Million), 2020-2035
  • Figure 50: Brazil COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 51: Europe COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 52: Europe COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 53: Europe Total COVID-19 Tests per thousand people, May 18, 2020
  • Figure 54: Europe COVID-19 Testing Policies, May 20,2020
  • Figure 55: Europe COVID-19 Data, Last Updated to 22nd May, 2020
  • Figure 56: Europe Population Projection (In Million), 2020-2035
  • Figure 57: Europe COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 58: Europe COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 59: Europe COVID-19 Diagnostic Testing Market Share- By Country, By Value, Year 2020 & 2025
  • Figure 60: Germany COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 61: Germany COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 62: Germany COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 63: Germany COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 64: Germany Population Projection (In Million), 2020-2035
  • Figure 65: Germany COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 66: France COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 67: France COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 68: France COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 69: France COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 70: France Population Projection (In Million), 2020-2035
  • Figure 71: France COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 72: United Kingdom COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 73: United Kingdom COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 74: United Kingdom COVID-19 regional test sites
  • Figure 75: United Kingdom COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 76: United Kingdom COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 77: United Kingdom Population Projection (In Million), 2020-2035
  • Figure 78: United Kingdom COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 79: Spain COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 80: Spain COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 81: Spain COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 82: Spain COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 83: Spain Population Projection (In Million), 2020-2035
  • Figure 84: Spain COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 85: Italy COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 86: Italy COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 87: Italy COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 88: Italy COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 89: Italy Population Projection (In Million), 2020-2035
  • Figure 90: Italy Total number of ICU beds, 2015-2020
  • Figure 91: Italy COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 92: Russia COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 93: Russia COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 94: Russia COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 95: Russia COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 96: Russia Population Projection (In Million), 2020-2035
  • Figure 97: Russia COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 98: Regions with highest coronavirus test conducted in Russia as of 20th May, 2020
  • Figure 99: Asia Pacific COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 100: Asia Pacific COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 101: Asia Pacific Total COVID-19 Tests per thousand people, May 18, 2020
  • Figure 102: Asia Pacific COVID-19 Testing Policies, May 20,2020
  • Figure 103: Asia COVID-19 Data, Last Updated to 24th May, 2020
  • Figure 104: Asia Population Projection (In Million), 2020-2035
  • Figure 105: Asia Pacific COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 106: Asia Pacific COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 107: Asia Pacific COVID-19 Diagnostic Testing Market Share- By Country, By Value, Year 2020 & 2025
  • Figure 108: China COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 109: China COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 110: Coronavirus Testing In China
  • Figure 111: China COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 112: China COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 113: China Population Projection (In Million), 2020-2035
  • Figure 114: China COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 115: Japan COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 116: Japan COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 117: Japan COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 118: Japan COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 119: Japan Population Projection (In Million), 2020-2035
  • Figure 120: Japan COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 121: Cumulative number of people underwent polymerase chain reaction (PCR) tests for coronavirus (COVID-19) in Japan as of May 22, 2020, by type of patients
  • Figure 122: India COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 123: India COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 124: India COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 125: India COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 126: India Population Projection (In Million), 2020-2035
  • Figure 127: India COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 128: South Korea COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 129: South Korea COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 130: South Korea COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 131: South Korea COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 132: South Korea Population Projection (In Million), 2020-2035
  • Figure 133: South Korea COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 134: Singapore COVID-19 Diagnostic Testing Market Size, By Value, 2020-2025 (USD Million)
  • Figure 135: Singapore COVID-19 Diagnostic Testing Market Size, By COVID-19 Tests, 2020-2025 (In Thousand)
  • Figure 136: Singapore COVID-19 Diagnostic Testing Market (By Test Type), By Value (USD Million), 2020-2025
  • Figure 137: Singapore COVID-19 Diagnostic Testing Market (By End-User), By Value (USD Million), 2020-2025
  • Figure 138: Singapore Population Projection (In Million), 2020-2035
  • Figure 139: Singapore COVID-19 Data, Last Updated to 21st May, 2020
  • Figure 140: Biomerieux Annual Revenue (USD Million), Year 2014-2019
  • Figure 141: Biomerieux Net Income/Loss (USD Million), Year 2014-2019
  • Figure 142: Biomerieux Sales Revenue Split, By Application Segment (%), FY2019
  • Figure 143: Biomerieux Sales Revenue Split, By Geography (%), FY2019
  • Figure 144: Biomerieux R&D Expenses (USD Million), Year 2014-2018
  • Figure 145: Roche Holding AG Annual Revenue (USD Million), Year 2015-2019
  • Figure 146: Roche Holding AG Net Income/Loss (USD Million), Year 2015-2019
  • Figure 147: Roche Holding AG Sales Revenue Split, By Business Segment (%), FY2019
  • Figure 148: Roche Holding AG R&D Expenses (USD Million), Year 2015-2019
  • Figure 149: Siemens Healthineers Annual Revenue (USD Million), Year 2015-2019
  • Figure 150: Siemens Healthineers Net Income/Loss (USD Million), Year 2015-2019
  • Figure 151: Siemens Healthineers Sales Revenue Split, By Business Segment (%), FY2019
  • Figure 152: Siemens Healthineers Sales Revenue Split, By Geography (%), FY2019
  • Figure 153: Abbott Laboratories Annual Revenue (USD Million), Year 2015-2019
  • Figure 154: Abbott Laboratories Net Income/Loss (USD Million), Year 2015-2019
  • Figure 155: Abbott Laboratories Sales Revenue Split, By Business Segment (%), FY2019
  • Figure 156: Abbott Laboratories Sales Revenue Split, By Geography (%), FY2019
  • Figure 157: Becton Dickinson Annual Revenue (USD Million), Year 2015-2019
  • Figure 158: Becton Dickinson Net Income/Loss (USD Million), Year 2015-2019
  • Figure 159: Becton Dickinson Sales Revenue Split, By Business Segment (%), FY2019
  • Figure 160: Becton Dickinson Sales Revenue Split, By Geography (%), FY2019
  • Figure 161: Thermo Fisher Scientific Annual Revenue (USD Million), Year 2015-2019
  • Figure 162: Thermo Fisher Scientific Net Income/Loss (USD Million), Year 2015-2019
  • Figure 163: Thermo Fisher Scientific Sales Revenue Split, By Business Segment (%), FY2019
  • Figure 164: Thermo Fisher Scientific Sales Revenue Split, By Geography (%), FY2019
  • Figure 165: Thermo Fisher Scientific Sales Revenue Split, By Market (%), FY2019
  • Figure 166: Thermo Fisher Scientific Sales Revenue Split, By Product (%), FY2019
  • Figure 167: Cepheid Annual Revenue (USD Million), Year 2015-2019
  • Figure 168: Cepheid Net Income/Loss (USD Million), Year 2015-2019
  • Figure 169: Cepheid Sales Revenue Split, By Business Segment (%), FY2019
  • Figure 170: Cepheid Sales Revenue Split, By Geography (%), FY2019
  • Figure 171: BGI Genomics Annual Revenue (USD Million), Year 2015-2019
  • Figure 172: BGI Genomics Net Income/Loss (USD Million), Year 2015-2019
  • Figure 173: Seegene Annual Revenue (USD Million), Year 2015-2019
  • Figure 174: Seegene Net Income/Loss (USD Million), Year 2015-2019
  • Figure 175: PerkinElmer Annual Revenue (USD Million), Year 2015-2019
  • Figure 176: PerkinElmer Net Income/Loss (USD Million), Year 2015-2019
  • Figure 177: PerkinElmer Sales Revenue Split, By Business Segment (%), FY2019
  • Figure 178: PerkinElmer Sales Revenue Split, By Geography (%), FY2019

List of Tables

  • Table A: Main manufacturers of COVID-19 PCR test kits, and estimates of their production capacities
  • Table B: Main manufacturers of COVID-19 test kits, and estimates of their production capacities (Continued)
  • Table C: Main manufacturers of COVID-19 test kits, and estimates of their production capacities (Continued)
  • Table D: Main manufacturers of COVID-19 test kits, and estimates of their production capacities (Continued)
  • Table E: Theoretical throughputs on the automated PCR machines from the key players
  • Table F: Theoretical throughputs on the automated PCR machines from the key players (Continued)
  • Table G: WHO COVID-19 Reference Laboratory Network (Updated on 19th April,2020)
  • Table H: WHO COVID-19 Reference Laboratory Network (Updated on 19th April,2020) (Continued)
  • Table I: Some of the Test kit Manufacturers and Commercial Laboratories
  • Table J: Comparison of Case fatality Ratios for SARS, COVID-19 and seasonal influenza
  • Table K: Test run as a percentage of population for certain countries
  • Table L: Few Major Players in Americas COVID-19 Diagnostic Testing Market
  • Table M: Theoretical throughputs on the automated PCR machines from the key players
  • Table N: Theoretical throughputs on the automated PCR machines from the key players (Continued)
  • Table O: COVID-19 Testing Device Applications Authorized by Health Canada
  • Table P: COVID-19 Testing Device Applications Authorized by Health Canada (Continued)
  • Table Q: COVID-19 Testing Device Applications Authorized by Health Canada (Continued)
  • Table R: Few Major Players in Europe COVID-19 Diagnostic Testing Market
  • Table S: Breakdown of Testing by 3 of the testing strategy pillars
  • Table T: Pillar 2 breakdown of test types
  • Table U: COVID-19 Italy Situation Report as of 24th May, 2020, By Region
  • Table V: Few Major Players in Asia Pacific COVID-19 Diagnostic Testing Market
  • Table W: Overview of the leading vaccine candidates (Continued)
  • Table X: Overview of the leading vaccine candidates